Mit Magzter GOLD unbegrenztes Potenzial nutzen

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$149.99
 
$74.99/Jahr
The Perfect Holiday Gift Gift Now

Career In Stem Cell Research

Healthcare Radius

|

January 2018

It is a misconception that only people with medical education background can be employed in stem cell therapy space

- Vipul Jain

Career In Stem Cell Research

Stem cell research is emerging as one of the most viable career options for youngsters, willing to take on a variety of challenges. So, what exactly does stem cell research involve? It is an advanced level of scientific research carried out by people from diverse science backgrounds to find new and efficient therapies for various ailments. The next level leading from stem cell research is stem cell therapeutic procedures. Stem cell treatment or therapy refers to introducing new adult stem cells into damaged tissue to treat a particular type of disease. The field of stem cell research and therapy offers lucrative career options for people looking for something different and revolutionary in the field of medical science. Very recently, a child afflicted by autism and a young woman suffering from rheumatoid arthritis have been completely cured through stem cell therapy, where conventional treatment procedures failed to yield positive results.

Is it true that only medical professionals are eligible for a successful career in stem cell research and therapy? The answer is in the negative. There is a general misconception that only people with medical education background can be employed in stem cell therapy space. In fact, students of basic biology too can find jobs in stem cell research and therapy. BSc graduates with at least one subject of Biological Sciences, MBBS or BPharma or BDS or BVSc or BE Biotechnology students can find jobs in the stem cell research domain.

WEITERE GESCHICHTEN VON Healthcare Radius

Healthcare Radius

Healthcare Radius

VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM

Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.

time to read

1 mins

December 2025

Healthcare Radius

Healthcare Radius

A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026

The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.

time to read

12 mins

December 2025

Healthcare Radius

Healthcare Radius

FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA

From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.

time to read

6 mins

December 2025

Healthcare Radius

ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US

Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS

Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL

Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH

Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS

By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”

time to read

7 mins

December 2025

Healthcare Radius

Healthcare Radius

MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM

Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.

time to read

1 min

December 2025

Translate

Share

-
+

Change font size

Holiday offer front
Holiday offer back